Influence of the Preparation Method on the Physicochemical Properties of Tolbutamide/Cyclodextrin Binary Systems

Tolbutamide (TBM) was found to form an inclusion complex with β-cyclodextrin (β-CD) in solution and in solid state. Inclusion complex formation between tolbutamide and β-cyclodextrin in aqueous solution was studied by phase solubility and spectral shift methods. The apparent stability constant Ks calculated by these techniques, in water, were estimated as 195.7 and 236.5 M−1, respectively. The phase solubility studies revealed a BS-type diagram with an inclusion complex of 1:2 molar ratio. The solid inclusion complexes of TBM and β-CD were prepared at a molar ratio of 1:2 by kneading, coprecipitation, freeze-drying, and spray-drying methods. In addition, the physical mixture was prepared. Characterization of TBM:β-CD inclusion was performed using differential scanning calorimetry (DSC), Raman spectroscopy, and X-ray diffractometry and by application of a so-called ether wash method. All the inclusion systems investigated led to a significant improvement in the dissolution over free TBM, and the dissolution rate of the active material was observed to be independent of the preparation method.

[1]  K. Uekama,et al.  Cyclodextrins in drug carrier systems. , 1987, Critical reviews in therapeutic drug carrier systems.

[2]  Joel H. Hildebrand,et al.  A Spectrophotometric Investigation of the Interaction of Iodine with Aromatic Hydrocarbons , 1949 .

[3]  A. Bolt,et al.  Quantitative studies of urinary excretion of chlorpromazine metabolites in chronically-dosed psychiatric patients. , 1966, Journal of pharmaceutical sciences.

[4]  N. Ozdemir,et al.  Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin. , 1998, Drug development and industrial pharmacy.

[5]  T. Nagai,et al.  Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with alpha- and beta-cyclodextrins in powdered form. , 1975, Chemical & pharmaceutical bulletin.

[6]  A. C. Eissens,et al.  β-Cyclodextrin as an excipient in solid oral dosage forms: in vitro and in vivo evaluation of spray-dried diazepam-β-cyclodextrin products , 1989 .

[7]  A. C. Eissens,et al.  The effects of cyclodextrins on drug release from fatty suppository bases : II. In vivo observations , 1991 .

[8]  A. Karara,et al.  Characterization, dissolution and bioavailability in rats of ibuprofen-β-cyclodextrin complex system , 1986 .

[9]  M Gibaldi,et al.  Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. , 1966, Journal of pharmaceutical sciences.

[10]  C. A. Ventura,et al.  Improvement of water solubility and dissolution rate of ursodeoxycholic acid and chenodeoxycholic acid by complexation with natural and modified β-cyclodextrins , 1997 .

[11]  S. Furlanetto,et al.  Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems. , 1999, International journal of pharmaceutics.

[12]  S. Lincoln,et al.  Inclusion Complexes of the Cyclomalto-Oligosaccharides (Cyclodextrins) , 1988 .

[13]  Osama A. Soliman,et al.  Amorphous spironolactone-hydroxypropylated cyclodextrin complexes with superior dissolution and oral bioavailability , 1997 .

[14]  J. Mielcarek.  Analytical Study of Photodegradation of Inclusion Complexes of Nimodipine with α-, γ-Cyclodextrin, Methyl-β-Cyclodextrin, and Hydroxypropyl-β-Cyclodextrin , 1998 .

[15]  Y. L. Loukas,et al.  The formation of an inclusion complex of methocarbamol with hydroxypropyl-β-cyclodextrin: the effect on chemical stability, solubility and dissolution rate , 1997 .

[16]  A. Chauvet,et al.  Etude thermoanalytique et lyodisponibilite de dispersions solides du tolbutamide , 1994 .

[17]  Jonathan Hadgraft,et al.  Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC , 1990 .

[18]  J. McGinty,et al.  Combined water-soluble carriers for coprecipitates of tolbutamide. , 1982, Journal of pharmaceutical sciences.

[19]  D. Duchěne,et al.  In vivo evaluation of indomethacin/ cyclodextrin complexes gastrointestinal tolerance and dermal anti-inflammatory activity , 1994 .

[20]  T. Higuchi,et al.  Phase solubility techniques , 1965 .

[21]  Wolfram Saenger,et al.  Cyclodextrin Inclusion Compounds in Research and Industry , 1980 .

[22]  K. H. Kim,et al.  Application of differential scanning calorimetry to the study of solid drug dispersions. , 1985, Journal of pharmaceutical sciences.

[23]  M. Huffman,et al.  Comparison of tolbutamide β-cyclodextrin inclusion compounds and solid dispersions: Physicochemical characteristics and dissolution studies , 1990 .

[24]  N. Çelebi,et al.  A study of the inclusion complex of naproxen with β-cyclodextrin , 1988 .

[25]  Mohammad A. Hassan,et al.  Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrin , 1990 .

[26]  J. B. Méndez,et al.  Reduction in the ulcerogenicity of naproxen by complexation with β-cyclodextrin , 1991 .

[27]  K. S. Kumaran,et al.  Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin. , 1998, Drug development and industrial pharmacy.

[28]  K. A. Connors,et al.  Theoretical analysis of comparative studies of complex formation. , 1966, Journal of pharmaceutical sciences.